Rivpra Formulation, an integrated pharmaceutical company, today announced its entry into the D2C segment with the launch...
As contract manufacturing becomes the new growth driver of the pharmaceutical industry, Piramal Alternatives, the fund m...
Stay updated on pharma trends and marketplace opportunities.